Table 2 Angiographic and interventional therapy characteristics according to Definition I
SMuRFs-present ACS (n = 5296) | SMuRFs-absent ACS (n = 392) | P-value | |
|---|---|---|---|
No. of target vessel | - | - | 0.036 |
1 | 4092 (78.03%) | 312 (81.46%) | - |
2 | 837 (15.96%) | 43 (11.23%) | - |
3 | 315 (6.01%) | 28 (7.31%) | - |
Target vessel location | - | - | - |
LM | 201 (3.80%) | 21 (5.36%) | 0.123 |
LAD | 3146 (59.40%) | 245 (62.50%) | 0.228 |
LCX | 1298 (24.51%) | 70 (17.86%) | 0.003 |
RCA | 1846 (34.86%) | 121 (30.87%) | 0.109 |
Complex lesions | - | - | - |
Total occlusion | 207 (3.91%) | 9 (2.30%) | 0.107 |
Bifurcation | 244 (4.61%) | 22 (5.61%) | 0.363 |
Diffuse lesion | 1995 (37.67%) | 126 (32.14%) | 0.029 |
Small vessel | 311 (5.87%) | 23 (5.87%) | 0.997 |
Thrombus | 570 (10.76%) | 54 (13.78%) | 0.066 |
No. of stents | 1.63 ± 0.90 | 1.50 ± 0.78 | 0.003 |
RVD | 3.04 ± 0.45 | 3.05 ± 0.48 | 0.603 |
Total length of stents, mm | 41.19 ± 26.13 | 37.11 ± 22.74 | 0.001 |